Sagimet Biosciences Inc (SGMT)
4.32
-0.13
(-2.92%)
USD |
NASDAQ |
May 03, 16:00
4.32
0.00 (0.00%)
After-Hours: 20:00
Sagimet Biosciences Total Assets (Quarterly): 96.72M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 96.72M |
September 30, 2023 | 102.92M |
June 30, 2023 | 21.50M |
Date | Value |
---|---|
March 31, 2023 | 27.25M |
December 31, 2022 | 33.03M |
March 31, 2021 | 77.20M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
21.50M
Minimum
Jun 2023
102.92M
Maximum
Sep 2023
59.77M
Average
55.12M
Median
Total Assets (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 640.55M |
89bio Inc | 596.27M |
Viking Therapeutics Inc | 967.52M |
Akero Therapeutics Inc | 580.27M |
Arrowhead Pharmaceuticals Inc | 626.29M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 5.654M |
Shareholders Equity (Quarterly) | 91.06M |